Literature DB >> 9472700

Pyruvate kinase isoenzyme shift from L-type to M2-type is a late event in hepatocarcinogenesis induced in rats by a choline-deficient/DL-ethionine-supplemented diet.

H J Hacker1, P Steinberg, P Bannasch.   

Abstract

Rats received a choline-deficient diet containing 0.1% (w/w) DL-ethionine (CDE) for 4, 10, 14 or 22 weeks. A separate group was treated for 4 weeks with CDE and then received a normal diet for 4 weeks. The L and M2 isoenzymes of pyruvate kinase were immunocytochemically demonstrated in liver sections. L-PK expression was strongly reduced in the hepatocytes after 4 weeks of treatment and remained low until the end of the study. Withdrawal of CDE after 4 weeks followed by 4 weeks normal diet resulted in a nearly full recovery of L-PK expression as compared to untreated controls. At later stages (10-22 weeks of CDE- treatment) many pseudolobules, preneoplastic foci of altered hepatocytes (FAH) such as combined clear/acidophilic cell foci (CCF/ACF) and mixed/basophilic cell foci (MCF/BCF), and hepatocellular adenomas (HCA) were observed. Pseudolobules showed a slight reduction in L-PK-expression, and were negative for M2-PK. In all clear cell components of CCF/ACF excessively storing glycogen, L-PK-expression was increased compared to both the surrounding parenchyma and hepatocytes of controls. In acidophilic cell components with less pronounced glycogen storage L-PK expression was similar to that of pseudolobules showing a slightly reduced content of this enzyme protein. M2-PK was invariably negative in CCF/ACF. In most MCF glycogen-storing subpopulations expressed L-PK, whereas in all glycogen-poor basophilic populations L-PK protein was strongly reduced. M2-PK was not expressed in most of these MCF. However, in rare MCF the reduction in L-PK expression was combined with a significant expression of M2-PK. In HCA M2-PK underwent a further increase, although to a variable degree, while L-PK remained strongly reduced. Our results show that an isoenzyme shift from L-PK to M2-PK takes place at a late stage of the hepatocarcinogenic process, and that those MCF with a low L-PK expression and a reexpression of M2-PK most probably represent the direct precursor lesions of hepatocellular neoplasms.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9472700     DOI: 10.1093/carcin/19.1.99

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  29 in total

1.  Pyruvate kinase M2 regulates gene transcription by acting as a protein kinase.

Authors:  Xueliang Gao; Haizhen Wang; Jenny J Yang; Xiaowei Liu; Zhi-Ren Liu
Journal:  Mol Cell       Date:  2012-02-02       Impact factor: 17.970

2.  Enhancing mitochondrial respiration suppresses tumor promoter TPA-induced PKM2 expression and cell transformation in skin epidermal JB6 cells.

Authors:  Jennifer A Wittwer; Delira Robbins; Fei Wang; Sarah Codarin; Xinggui Shen; Christopher G Kevil; Ting-Ting Huang; Holly Van Remmen; Arlan Richardson; Yunfeng Zhao
Journal:  Cancer Prev Res (Phila)       Date:  2011-06-14

3.  Role of pyruvate kinase M2 in transcriptional regulation leading to epithelial-mesenchymal transition.

Authors:  Atsushi Hamabe; Masamitsu Konno; Nobuhiro Tanuma; Hiroshi Shima; Kenta Tsunekuni; Koichi Kawamoto; Naohiro Nishida; Jun Koseki; Koshi Mimori; Noriko Gotoh; Hirofumi Yamamoto; Yuichiro Doki; Masaki Mori; Hideshi Ishii
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-13       Impact factor: 11.205

4.  Colorectal cancer screening by non-invasive metabolic biomarker fecal tumor M2-PK.

Authors:  Carolin Tonus; Gero Neupert; Markus Sellinger
Journal:  World J Gastroenterol       Date:  2006-11-21       Impact factor: 5.742

5.  Modulation of type M2 pyruvate kinase activity by the human papillomavirus type 16 E7 oncoprotein.

Authors:  W Zwerschke; S Mazurek; P Massimi; L Banks; E Eigenbrodt; P Jansen-Dürr
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

6.  Pyruvate kinase isoform expression alters nucleotide synthesis to impact cell proliferation.

Authors:  Sophia Y Lunt; Vinayak Muralidhar; Aaron M Hosios; William J Israelsen; Dan Y Gui; Lauren Newhouse; Martin Ogrodzinski; Vivian Hecht; Kali Xu; Paula N Marín Acevedo; Daniel P Hollern; Gary Bellinger; Talya L Dayton; Stefan Christen; Ilaria Elia; Anh T Dinh; Gregory Stephanopoulos; Scott R Manalis; Michael B Yaffe; Eran R Andrechek; Sarah-Maria Fendt; Matthew G Vander Heiden
Journal:  Mol Cell       Date:  2014-12-04       Impact factor: 17.970

7.  Influence of serum from liver-damaged rats on differentiation tendency of bone marrow-derived stem cells.

Authors:  Hai Hong; Jian-Zhi Chen; Feng Zhou; Ling Xue; Guo-Qiang Zhao
Journal:  World J Gastroenterol       Date:  2004-08-01       Impact factor: 5.742

Review 8.  A critical review of the role of M2PYK in the Warburg effect.

Authors:  Robert A Harris; Aron W Fenton
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2019-01-29       Impact factor: 10.680

9.  PARP Inhibition Suppresses Growth of EGFR-Mutant Cancers by Targeting Nuclear PKM2.

Authors:  Nan Li; Lin Feng; Hui Liu; Jiadong Wang; Moses Kasembeli; My Kim Tran; David J Tweardy; Steven Hsesheng Lin; Junjie Chen
Journal:  Cell Rep       Date:  2016-04-14       Impact factor: 9.423

10.  PKM2 released by neutrophils at wound site facilitates early wound healing by promoting angiogenesis.

Authors:  Yinwei Zhang; Liangwei Li; Yuan Liu; Zhi-Ren Liu
Journal:  Wound Repair Regen       Date:  2016-03-10       Impact factor: 3.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.